When was Molbio Diagnostics founded?

Molbio Diagnostics was founded in 2000 and raised its 1st funding round 20 years after it was founded.

Where is Molbio Diagnostics located?

Molbio Diagnostics is headquartered in Salcete, India. It is registered at Plot No.L-46, Phase II-D Verna Industrial Area,Verna, South Goa, Salcete, Goa, India, 403722.

Which legal entities is Molbio Diagnostics associated with?

Molbio Diagnostics is associated with MOLBIO DIAGNOSTICS LIMITED and 2 others.

How many employees does Molbio Diagnostics have?

As of May 31, 2025, the latest employee count at Molbio Diagnostics is 714.

Is Molbio Diagnostics a funded company?

Molbio Diagnostics is a funded company, having raised a total of $124M across 4 funding rounds to date. The company's 1st funding round was a $19.7M Series B round, raised on Jan 22, 2020.

When was the latest funding round of Molbio Diagnostics?

Molbio Diagnostics' latest funding was a Grant (prize money) round on 2023, with participation from 1 investor.

What is the annual revenue of Molbio Diagnostics?

Annual revenue of Molbio Diagnostics is more than ₹1,000 Cr as on Mar 31, 2025

Is Molbio Diagnostics a Genomics company?

The primary sectors of Molbio Diagnostics are Genomics and Infectious Diseases.

Where does Molbio Diagnostics rank among its competitors?

Molbio Diagnostics ranks 1st amongst 139 active competitors, of which 30 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Alveo Technologies, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Molbio Diagnostics?

Molbio Diagnostics' top competitors include Lumos Diagnostics, ChromaCode and DermTech. Among them, Alveo Technologies secured the most recent funding round in May, 2026.

Molbio Diagnostics - 2026 Company Profile, Team, Funding, Competitors & Financials

Sectors and market segments that Molbio Diagnostics operate in

Molbio Diagnostics serves in the Life Sciences, Sustainability Tech market segments.The primary business model of Molbio Diagnostics are:

Company Details

Developer of point-of-care molecular diagnostic platform for infectious disease detection. The solution includes Trueprep a fully automatic universal cartridge-based sample prep device, Prolab Atlus portable x-ray system, Thermalytix AI-based thermal scanning device, and Truelab, a real-time, quantitative micro-PCR analyzer that targets diseases like rifampicin resistance, COVID‑19, influenza, dengue, hepatitis, HPV, malaria, and others.

Website: www.molbiodiagnostics.com/
Social
Phone Number: +91 **********
Registered Address: Plot No.L-46, Phase II-D Verna Industrial Area,Verna, South Goa, Salcete, Goa, India, 403722

Key Metrics

Founded Year

2000

Location

Salcete, India

Stage

Public

Total Funding

$124M in 4 rounds

Latest Funding Round

Grant (prize money), 2023, Undisclosed

Investors

Motilal Oswal & 37 more

Ranked

1^st among 139 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2025

Employee Count

714 as on May 31, 2025

Investment & Acquisitions

Optra SCAN & 1 more

Similar Companies

Lumos Diagnostics & 93 more

Exit Details

Public

View Molbio Diagnostics' full profile

Molbio Diagnostics is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
MOLBIO s.r.o. CIN: 07212381 , Czech Republic, Active	Jun 14, 2018	$0 - $1M (As on Dec 31, 2023)	-
ENESAR CONSULTING PRIVATE LIMITED CIN: U93000MH2008PTC181487 , India, Active	Apr 23, 2008	₹100 - ₹500 Cr (As on Mar 31, 2025)	-
MOLBIO DIAGNOSTICS LIMITED CIN: L33125GA2000PLC002909 , India, Active	Oct 20, 2000	₹1,000+ Cr (As on Mar 31, 2025)	782 (As on Apr 01, 2026)

Molbio Diagnostics got listed on Aug 17, 2026.

Click here to take a look at Molbio Diagnostics's IPO in detail

Molbio Diagnostics has raised a total funding of $124M over 4 rounds. Its first funding round was on Jan 22, 2020. Its latest funding round was a Grant (prize money) round on 2023 for an undisclosed amount. 1 investor participated in its latest round. Molbio Diagnostics has 12 institutional investors and 26 angel investors.

Here is the list of recent funding rounds of Molbio Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2023	Undisclosed	Grant (prize money)	-	-	-	ACT Grants
Sep 22, 2022	$85M	Series C	$1.53B	20.9x	Temasek	Motilal Oswal Financial Services
May 28, 2021	$19.3M	Series B	$226M	1.3x	Motilal Oswal	-

Access funding benchmarks and valuations. Sign up today!

View details of Molbio Diagnostics's funding rounds and investors

The founders of Molbio Diagnostics is Chandrasekhar Nair.

Here are the details of Molbio Diagnostics' key team members:

Chandrasekhar Nair: Co-Founder & CTO of Molbio Diagnostics.
Contact Info: 1 email address and 1 phone number

Molbio Diagnostics' Board of Directors

Molbio Diagnostics's board has 8 active members. Sriram Natarajan, Chandrasekhar Nair and Ved Prakash Kalanoria are part of team and Rohit Ashok Kumar Mullangi, Sangeetha Sriram, Nupur Garg, Balram Bhargava and Arun Kumar Jha are independent board members.

Here is the list of Molbio Diagnostics' board of directors:

Name	Type	Representing	Status	Duration
Sriram Natarajan	Team	-	Current	2y 9m
Chandrasekhar Nair	Team	-	Current	13y 11m
Ved Prakash Kalanoria	Investor	-	Past	2y 6m
Sangeetha Sriram	Independent board member	-	Current	5y 8m
Nupur Garg	Independent board member	-	Current	1y 6m
Balram Bhargava	Independent board member	-	Current	1y 9m
Arun Kumar Jha	Independent board member	-	Current	1y 9m
Rohit Ashok Kumar Mullangi	Independent board member	-	Past	4y 0m

View details of Molbio Diagnostics's Founder profiles and Board Members

Molbio Diagnostics' employee count trend

Molbio Diagnostics has 714 employees as of May 25. The total employee count is 17.0% more than what it was in May 24. Here is Molbio Diagnostics's employee count trend over the years:

Employee count trend for Molbio Diagnostics

Uncover Molbio Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Molbio Diagnostics include Lumos Diagnostics, ChromaCode and DermTech. Here is the list of Top 10 competitors of Molbio Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Molbio Diagnostics 2000, Salcete (India), Public	Developer of point-of-care molecular diagnostic platform for infectious disease detection	$124M	Motilal Oswal, Temasek & 36 others	74/100
2nd	Lumos Diagnostics 2017, Carlsbad (United States), Public	Developer and manufacturer of point-of-care diagnostic tests and reader platforms	$40M	Perennial, Ellerston Capital & 2 others	58/100
3rd	ChromaCode 2012, Carlsbad (United States), Series C	Digital molecular biology analytics for disease management	$95M	Northpond Ventures, New Enterprise Associates ... & 9 others	55/100
4th	DermTech 1996, San Diego (United States), Acquired	Provider of adhesive patch biopsy for skin cancer diagnostics	$24.4M	RTW Investments, Van Herk Groep & 3 others	54/100
5th	Biofire Diagnostics 1990, Salt Lake City (United States), Acquired	Provider of molecular diagnostic solutions for the detection of genetic conditions	$84M	Founders Fund, Athyrium Capital Management ... & 8 others	54/100
6th	SD Biosensor 2001, Suwon-si (South Korea), Public	Provider of point-of-care diagnostics for multiple diseases	-	Gates, InterVest & 3 others	53/100
7th	Diagnoplex 2005, Lausanne (Switzerland), Acquired	Molecular diagnostics for colorectal cancer.	$9.68M	NeoMed, Novartis Venture Fund & 2 others	53/100
8th	Proxim Diagnostics 2010, Sunnyvale (United States), Series B	Developer of a handheld immunodiagnostic device for cardiac vascular diseases	$22.9M	BioMerieux, UCLA Ventures & 1 others	52/100
9th	NeuMoDx 2012, Ann Arbor (United States), Acquired	Developer of a platform for low cost molecular testing	$66M	Arboretum Ventures, Wolverine Venture Fund ... & 3 others	52/100
10th	Alveo Technologies 2015, Alameda (United States), Series A	Developer of a portable molecular diagnostics platform	$63.6M	4-Good Ventures, Celesta Capital & 8 others	49/100